FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to resuscitation, and can be used for determination of readiness of weaning from artificial pulmonary ventilation (APV) of patients with cerebral injuries. Peripheral chemoreflex sensitivity is quantitatively assessed by evaluating external respiration values: minute volume of respiration (MVR) in l/min, respiratory rate (RR) in min-1, respiratory volume (RV) in l/min initially and after carrying out functional loading test. Sample is carried out in the form of independent breathing with oxygen-air mixture 1:1 using a closed breathing circuit of the rebreather, in which the oxygen content decreases as it is absorbed by the patient's body, until the first episode of desaturation of hemoglobin with oxygen spO2 in range of 90–80 %. Peripheral chemoreceptor sensitivity index is calculated by formula PCSI=(RRi:RRe)×(RVi:RVe)×(MVRi:MVRe)×RVe×MVRe, where PCSI is the peripheral chemoreceptor sensitivity index; RRi is the respiratory rate initially before the functional loading test; RRe is respiratory rate when saturation of hemoglobin with oxygen – spO2, in range of 90–80 %; RVi – respiratory volume initially before carrying out functional loading test (l/min); RVe – respiratory volume with oxygen saturation of hemoglobin – spO2, in range of 90–80 % (l/min); MVRi is a minute volume of respiration recorded initially before the functional loading test (l/min); MVRe is a minute volume of breathing when saturation of hemoglobin with oxygen – spO2 in range of 90–80 % (l/min). If values of PCSI are more than 31 make a conclusion on the possibility of successful implementation of programs for weaning from artificial pulmonary ventilation.
EFFECT: method provides an individual assessment of the possibility of a patient on APV to breathe independently by determining the sensitivity of the chemoreflex on the background of the functional load.
1 cl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR ARTIFICIAL VOLUME-CONTROLLED LUNG VENTILATION | 2001 |
|
RU2207159C2 |
METHOD FOR CARRYING OUT PROLONGED ARTIFICIAL PULMONARY VENTILATION | 2003 |
|
RU2255723C2 |
METHOD FOR TRANSFERRING PATIENTS HAVING VERTEBRAL COLUMN LESION AT CERVICAL LEVEL TO SPONTANEOUS RESPIRATION MODE | 2004 |
|
RU2268757C2 |
METHOD FOR SELECTING WAY FOR TRANSFERRING CRANIOCEREBRAL INJURY PATIENTS TO SELF- STANDING BREATHING | 2002 |
|
RU2223121C2 |
A METHOD FOR DIAGNOSING LATENT RESPIRATORY FAILURE IN PATIENTS WITH PNEUMONIA | 2022 |
|
RU2790920C1 |
METHOD OF INSTANT DIAGNOSTICS OF RESPIRATORY FAILURE | 2020 |
|
RU2740115C1 |
METHOD OF CHOOSING TACTICS FOR CORRECTING ACUTE RESPIRATORY FAILURE IN PATIENTS WITH COVID-19 | 2023 |
|
RU2807934C1 |
METHOD OF REHABILITATION, COMBINING HYPO- AND HYPERBARIC OXYGENATION, FOR PATIENTS SUFFERING NEW CORONAVIRUS INFECTION | 2023 |
|
RU2821549C1 |
METHOD OF GENERAL ANESTHESIA WITH PRESERVED SPONTANEOUS BREATHING FOR MEDIUM- AND LOW-TRAUMATIC SURGICAL OPERATIONS | 2018 |
|
RU2703686C1 |
METHOD FOR USING GUARANTEED TIDAL VOLUME IN NEWBORNS WITH SEVERE RESPIRATORY PATHOLOGY, MANIFESTED BY RESPIRATORY FAILURE OF II-III SEVERITY | 2021 |
|
RU2750841C1 |
Authors
Dates
2019-07-02—Published
2018-06-29—Filed